This exchange-traded fund consists of 18 biotech companies and is used by many traders to predict the overall direction of this particular sector. As you can see from the chart below, BBH has been trading within a descending channel since November and has recently bounced off the support of the 200 DMA to close near the resistance of the upper trendline ($195). It will be interesting to see if the bulls can push the price above the descending trendline or if BBH will remain range-bound and continue to drift lower.



BBH_022206.jpg

You May Also Like

Related Analysis
  1. Stock Analysis

    Celgene's $1 Billion Deal to Fight Cancer

  2. Stock Analysis

    The Fall of the Chinese Stock Exchange and its Impact on Alibaba, Youku Tudou, and ...

  3. Stock Analysis

    Obamacare Affirmed - What's the Investing Impact?

  4. Stock Analysis

    Sarepta Therapeutics One Step Closer to Drug Approval

  5. Stock Analysis

    Lions Gate to Bring Iconic Game to the Big Screen

Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!